[صفحه اصلی ]   [Archive]  
:: صفحه اصلي :: درباره نشريه :: آخرين شماره :: تمام شماره‌ها :: جستجو :: ثبت نام :: ارسال مقاله :: تماس با ما ::
بخش‌های اصلی
صفحه اصلی::
اطلاعات نشریه::
آرشیو مجله و مقالات::
برای نویسندگان::
برای داوران::
ثبت نام و اشتراک::
تماس با ما::
تسهیلات پایگاه::
بایگانی مقالات زیر چاپ::
::
جستجو در پایگاه

جستجوی پیشرفته
..
دریافت اطلاعات پایگاه
نشانی پست الکترونیک خود را برای دریافت اطلاعات و اخبار پایگاه، در کادر زیر وارد کنید.
..
:: دوره 1، شماره 2 - ( 3-1394 ) ::
برگشت به فهرست نسخه ها
Thyroid-stimulating hormone (TSH) and pregnancy outcome in patients undergoing in vitro fertilization (IVF)
:   (10992 مشاهده)

Introduction: Subclinical hypothyroidism is related to poor outcome of pregnancy, which is reported in more recent researches. The aim of this study was to determine the correlation between pre-conception of thyroid-stimulating hormone (TSH) level and pregnancy outcomes in patients undergoing in vitro fertilization (IVF).

 Methods: This retrospective cohort study was done on 115 IVF candidate patients undergoing long protocol of ovulation induction that became pregnant from 2007 to 2012. Pregnancy outcomes, including abortion rate, termination age of pregnancy and birth weight in women with low pre-conception TSH (≤2.5 mIU/L) and high pre-conception TSH (>2.5 mIU/L) were compared with each other.

Results: Among 115 pregnancies, 30.2% of the women had pre-conception TSH >2.5 mIU/L. Preterm delivery (<32 weeks) was higher in patients with a pre-conception TSH >2.5 than them with a pre-conception TSH ≤2.5 (P= 0.044). There was no statistically significant difference in abortion, pregnancy termination, and birth weight between two groups. A pre-conception thyroid-stimulating hormone level >2.5 mIU/L is associated with a lower gestational age at delivery in women undergoing in vitro fertilization.

Conclusion: The results of this research indicated that a pre-conception thyroid-stimulating hormone level >2.5 associated with preterm labor in women undergoing IVF. Therefore, it is suggested that screening for hypothyroidism before IVF could be have significant public health implications. 

     
نوع مطالعه: پژوهشي | موضوع مقاله: Obstetrics and Gynecology
دریافت: 1393/11/16 | پذیرش: 1394/3/1 | انتشار: 1394/3/6
ارسال نظر درباره این مقاله
نام کاربری یا پست الکترونیک شما:

CAPTCHA


XML   English Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Abedi Samakoosh M, Bouzari Z, Yazdani S, Rashidi F, Golsorkhtabaramiri M. Thyroid-stimulating hormone (TSH) and pregnancy outcome in patients undergoing in vitro fertilization (IVF). Caspian J Reprod Med 2015; 1 (2) :1-4
URL: http://caspjrm.ir/article-1-53-fa.html

Thyroid-stimulating hormone (TSH) and pregnancy outcome in patients undergoing in vitro fertilization (IVF). نشریه طب تولید مثل خزر. 1394; 1 (2) :1-4

URL: http://caspjrm.ir/article-1-53-fa.html



بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.
دوره 1، شماره 2 - ( 3-1394 ) برگشت به فهرست نسخه ها
Caspian Journal of Reproductive Medicine
Caspian J Repord Med: Infertility and Reproductive Health Research Center of Babol University of Medical Sciences, Babol-Amol old highway, after Mohammadhasan Khan bridge, Babol, Mazandaran, Iran, P.O. Box: 47135-547 Tel: +98-11-32274881-2 Fax: +98-11-32274880 E-mail: info@caspjrm.ir Website: www.caspjrm.ir
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4645